EUVIMEDEUVIMED entdecken
Crossref

N4BP1 promotes the progression of acute glaucoma by promoting pyroptosis through the JAK2/STAT3 pathway

Nan Jiang, Jie Zhu, Jin Zhou, Wensi Chen, Zhenni Zhao, Wenxiang Lin, Ying Yu

Experimental Eye Research · 2026

DOI: 10.1016/j.exer.2026.110896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Eye Research, 2026. Verfasst von Nan Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. Electronic address: Jiang…. Hauptthemen laut MEDLINE: Pyroptosis, STAT3 Transcription Factor, Janus Kinase 2, Glaucoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute glaucoma is the common subtype of glaucoma with unclear mechanism, which is characterized by an abrupt increase in intraocular pressure (IOP) leading to irreversible vision loss. To elucidate the mechanisms underlying the progression of acute glaucoma, here we found that N4BP1, a pivotal regulator innate immune signaling and inflammation, is upregulated in acute glaucoma mice. Notably, knockdown of N4BP1 exhibited alleviation of acute glaucoma symptoms, along with a decrease in microglial activation and pyroptosis levels when compared with the ischemia-reperfusion model group. Subsequently, through the analysis of transcriptome sequencing results, we identified pyroptosis and JAK2/STAT3 as the potential downstream targets of N4BP1. We further confirmed that the JAK2/STAT3 pathway is indeed a critical factor in N4BP1-mediated regulation of microglial activity and pyroptosis levels in vitro. In conclusion, N4BP1 could modulate cell pyroptosis and the progression of acute glaucoma through the JAK2/STAT3 signaling pathway, suggesting its potential as a viable molecular target for the clinical treatment of acute glaucoma in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisSTAT3 Transcription FactorJanus Kinase 2GlaucomaGene Expression RegulationAnimalsMiceSignal TransductionDisease ProgressionDisease Models, AnimalMice, Inbred C57BLIntraocular PressureMicrogliaMaleAcute DiseaseBlotting, Western

Stichwörter der Autor:innen

JAK2/STAT3MicrogliaN4BP1acute glaucomapyroptosis

Substanzen

STAT3 Transcription FactorJanus Kinase 2Jak2 protein, mouseStat3 protein, mouse

Autor:innen und Institutionen

  • Department of Ophthalmology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. Electronic address: Jiangnan311323@163.com.
  • Department of Ophthalmology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
  • Department of Ophthalmology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. Electronic address: Yuying0318@163.com.

Zitieren

APA

Jiang, N., Zhu, J., Zhou, J., Chen, W., Zhao, Z., Lin, W., & Yu, Y. (2026). N4BP1 promotes the progression of acute glaucoma by promoting pyroptosis through the JAK2/STAT3 pathway. Experimental Eye Research. https://doi.org/10.1016/j.exer.2026.110896

Vancouver

Jiang N, Zhu J, Zhou J, Chen W, Zhao Z, Lin W, et al. N4BP1 promotes the progression of acute glaucoma by promoting pyroptosis through the JAK2/STAT3 pathway. Experimental Eye Research. 2026. doi:10.1016/j.exer.2026.110896

BibTeX
@article{Jiang2026,
  author = {Jiang, Nan and Zhu, Jie and Zhou, Jin and Chen, Wensi and Zhao, Zhenni and Lin, Wenxiang and Yu, Ying},
  title = {N4BP1 promotes the progression of acute glaucoma by promoting pyroptosis through the JAK2/STAT3 pathway},
  journal = {Experimental Eye Research},
  year = {2026},
  doi = {10.1016/j.exer.2026.110896}
}
Kostenlos starten →